156 related articles for article (PubMed ID: 16076253)
1. Partial correction of sensitivity to oxidant stress in Friedreich ataxia patient fibroblasts by frataxin-encoding adeno-associated virus and lentivirus vectors.
Fleming J; Spinoulas A; Zheng M; Cunningham SC; Ginn SL; McQuilty RC; Rowe PB; Alexander IE
Hum Gene Ther; 2005 Aug; 16(8):947-56. PubMed ID: 16076253
[TBL] [Abstract][Full Text] [Related]
2. Lentivirus-meditated frataxin gene delivery reverses genome instability in Friedreich ataxia patient and mouse model fibroblasts.
Khonsari H; Schneider M; Al-Mahdawi S; Chianea YG; Themis M; Parris C; Pook MA; Themis M
Gene Ther; 2016 Dec; 23(12):846-856. PubMed ID: 27518705
[TBL] [Abstract][Full Text] [Related]
3. Rapid and Complete Reversal of Sensory Ataxia by Gene Therapy in a Novel Model of Friedreich Ataxia.
Piguet F; de Montigny C; Vaucamps N; Reutenauer L; Eisenmann A; Puccio H
Mol Ther; 2018 Aug; 26(8):1940-1952. PubMed ID: 29853274
[TBL] [Abstract][Full Text] [Related]
4. Infectious delivery and expression of a 135 kb human FRDA genomic DNA locus complements Friedreich's ataxia deficiency in human cells.
Gomez-Sebastian S; Gimenez-Cassina A; Diaz-Nido J; Lim F; Wade-Martins R
Mol Ther; 2007 Feb; 15(2):248-54. PubMed ID: 17235301
[TBL] [Abstract][Full Text] [Related]
5. Functional recovery in a Friedreich's ataxia mouse model by frataxin gene transfer using an HSV-1 amplicon vector.
Lim F; Palomo GM; Mauritz C; Giménez-Cassina A; Illana B; Wandosell F; Díaz-Nido J
Mol Ther; 2007 Jun; 15(6):1072-8. PubMed ID: 17375064
[TBL] [Abstract][Full Text] [Related]
6. Adeno-associated virus and lentivirus vectors mediate efficient and sustained transduction of cultured mouse and human dorsal root ganglia sensory neurons.
Fleming J; Ginn SL; Weinberger RP; Trahair TN; Smythe JA; Alexander IE
Hum Gene Ther; 2001 Jan; 12(1):77-86. PubMed ID: 11177545
[TBL] [Abstract][Full Text] [Related]
7. Friedreich ataxia: an update on animal models, frataxin function and therapies.
González-Cabo P; Llorens JV; Palau F; Moltó MD
Adv Exp Med Biol; 2009; 652():247-61. PubMed ID: 20225031
[TBL] [Abstract][Full Text] [Related]
8. Small molecules affecting transcription in Friedreich ataxia.
Gottesfeld JM
Pharmacol Ther; 2007 Nov; 116(2):236-48. PubMed ID: 17826840
[TBL] [Abstract][Full Text] [Related]
9. Friedreich ataxia: a paradigm for mitochondrial diseases.
Puccio H; Koenig M
Curr Opin Genet Dev; 2002 Jun; 12(3):272-7. PubMed ID: 12076669
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia.
Sarsero JP; Li L; Wardan H; Sitte K; Williamson R; Ioannou PA
J Gene Med; 2003 Jan; 5(1):72-81. PubMed ID: 12516053
[TBL] [Abstract][Full Text] [Related]
11. Friedreich's ataxia: from disease mechanisms to therapeutic interventions.
Lodi R; Tonon C; Calabrese V; Schapira AH
Antioxid Redox Signal; 2006; 8(3-4):438-43. PubMed ID: 16677089
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin in Friedreich ataxia.
Mariotti C; Nachbauer W; Panzeri M; Poewe W; Taroni F; Boesch S
J Neurochem; 2013 Aug; 126 Suppl 1():80-7. PubMed ID: 23859343
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic developments in Friedreich ataxia.
Wilson RB
J Child Neurol; 2012 Sep; 27(9):1212-6. PubMed ID: 22791549
[TBL] [Abstract][Full Text] [Related]
14. Sustained FXN expression in dorsal root ganglia from a nonreplicative genomic HSV-1 vector.
Ventosa M; Wu Z; Lim F
J Gene Med; 2017 Nov; 19(11):376-386. PubMed ID: 29044877
[TBL] [Abstract][Full Text] [Related]
15. Milestones in Friedreich ataxia: more than a century and still learning.
Abrahão A; Pedroso JL; Braga-Neto P; Bor-Seng-Shu E; de Carvalho Aguiar P; Barsottini OG
Neurogenetics; 2015 Jul; 16(3):151-60. PubMed ID: 25662948
[TBL] [Abstract][Full Text] [Related]
16. Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia.
Perdomini M; Belbellaa B; Monassier L; Reutenauer L; Messaddeq N; Cartier N; Crystal RG; Aubourg P; Puccio H
Nat Med; 2014 May; 20(5):542-7. PubMed ID: 24705334
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic cell death and altered calcium homeostasis caused by frataxin depletion in dorsal root ganglia neurons can be prevented by BH4 domain of Bcl-xL protein.
Mincheva-Tasheva S; Obis E; Tamarit J; Ros J
Hum Mol Genet; 2014 Apr; 23(7):1829-41. PubMed ID: 24242291
[TBL] [Abstract][Full Text] [Related]
18. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits.
Puccio H; Simon D; Cossée M; Criqui-Filipe P; Tiziano F; Melki J; Hindelang C; Matyas R; Rustin P; Koenig M
Nat Genet; 2001 Feb; 27(2):181-6. PubMed ID: 11175786
[TBL] [Abstract][Full Text] [Related]
19. Understanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approaches.
Schmucker S; Puccio H
Hum Mol Genet; 2010 Apr; 19(R1):R103-10. PubMed ID: 20413654
[TBL] [Abstract][Full Text] [Related]
20. Cell and gene therapy for Friedreich ataxia: progress to date.
Evans-Galea MV; Pébay A; Dottori M; Corben LA; Ong SH; Lockhart PJ; Delatycki MB
Hum Gene Ther; 2014 Aug; 25(8):684-93. PubMed ID: 24749505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
